• Home (current)
  • La Società
    Chi siamo Soci collettivi Collaborazioni tecniche Bilancio societario
  • Sezioni Regionali
  • Convegni e Formazione
    Eventi SINU Altri eventi Eventi patrocinati
  • Newsletters
  • Cerca
  • Come iscriversi
  • Area Soci:
  • Registrati
  • Login
  • English version
  • Passa al contenuto principale

SINU

Società Italiana di Nutrizione Umana

EFSA – Sicurezza dell'estensione dell'uso dei galatto‐oligosaccaridi come novel food

The EFSA NDA Panel was asked to deliver an opinion on the extension of use of galacto‐oligosaccharides (GOS) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a syrup containing ≥ 57% w/w GOS (w/w dry matter), consisting of different galactosyl residues linked to a terminal glucose by a β‐glycosidic bond and also containing lactose and the constituent monomers of lactose (galactose and glucose). The NF is already authorised and included in the Union list of NFs and is produced according to the same production process. This application is limited to an assessment of the extension of use as a food ingredient in dairy confectionary, cheese and processed cheese, butter and spreads. There is a 10–30% increase in total GOS intake from the requested extension of use compared to the currently authorised uses at the highest 95th percentile. It is noted that the total intake at the highest mean (8.7–22.0 g/day) is below the adequate intake (AI) of 25 g/day for dietary fibre set to ensure a normal laxation in adults, while the highest 95th percentile (27.2–41.6 g/day) is higher than the AI. When the maximum use as a food supplement is added to the highest 95th percentile combined intake from all proposed and authorised food categories a total intake up to 58 g GOS/day is estimated. This highest intake level would exceed the AI for dietary fibre; however, no tolerable upper intake level for dietary fibre has been set and only transient gastrointestinal symptoms may be related to high intake of fibre. The Panel concludes that the NF, that is composed of ≥ 57% GOS dry matter, lactose and related saccharides, is safe under the proposed extension of use.

Consulta il documento


HOME

LARN IV revisione
NMCD
Meno sale più salute
Come iscriversi
Questionari
Il Punto su…
Congresso SINU 2019
Documenti SINU

LA SOCIETA'

Chi siamo
Soci collettivi
Collaborazioni tecniche
Biancio societario

FORMAZIONE

Eventi SINU
Altri eventi
Eventi patrocinati

NEWS

In evidenza
News recenti

CONTATTI

Sezioni regionali
Gruppi di lavoro
Privacy policy

SEGRETERIA SINU

c/o BioMedia srl
via Libero Temolo 4
20126 Milano
02 45498282
02 45498199
info@sinu.it

Copyright © 2019 SINU - Tutti i diritti riservati.


Un progetto realizzato da: BioMedia srl.

Recupera password

Presto Disponibile